![Jens-Peter Volkmer](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Jens-Peter Volkmer is the founder of Forty Seven, Inc., which was founded in 2014.
He held the title of Vice President-Research & Early Development at the company.
Currently, Dr. Volkmer is the Chief Executive & Financial Officer at Inograft Biotherapeutics, Inc. and Inograft Biotherapeutics, Inc. (United States).
Postes actifs de Jens-Peter Volkmer
| Sociétés | Poste | Début |
|---|---|---|
| FORTY SEVEN, INC. | Fondateur | 01/01/2014 |
48 Bio, Inc.
 48 Bio, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical and medicine | Directeur Général | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
9
Relations au 1er degré
2
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Forty Seven, Inc.
 Forty Seven, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for cancer treatment | Health Technology |
48 Bio, Inc.
48 Bio, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical and medicine | Health Technology |
Choisissez Zonebourse 
